ARTICLE | Management Tracks
Janssen vet Vratsanos joins Jnana as CMO
Plus: CureVac’s Splawski lands at Yarrow and updates from Genelux, Cour and more
July 21, 2023 11:28 PM UTC
Jnana Therapeutics Inc. hired George Vratsanos as CMO and head of R&D. Vratsanos joins the chemoproteomics company from Janssen Pharmaceuticals, where he was most recently SVP, translational science and medicine.
RTW-incubated company Yarrow Biotechnology Inc., which is developing nucleic acid therapeutics, hired Igor Splawski as CSO. Igor Splawski was CSO at CureVac N.V. (NASDAQ:CVAC), where he was succeeded by CDO Myriam Mendila...